Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GPAT
GPAT logo

GPAT Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy GP-Act III Acquisition Corp (GPAT) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
10.800
1 Day change
52 Week Range
11.210
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

GP-Act III Acquisition Corp (GPAT) is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is near its pre-market level of 10.8, but technicals are mixed to slightly weak, there are no strong proprietary buy signals, no recent news catalysts, and no meaningful hedge fund, insider, or congress activity to support an immediate purchase. This looks more like a wait-and-monitor name than an immediate long-term buy.

Technical Analysis

Price is trading in pre-market at 10.8, slightly below the pivot at 10.943 and near support at 10.779. MACD histogram is negative and expanding, which points to short-term weakness. RSI_6 at 43.696 is neutral, showing no clear momentum advantage. Moving averages are converging, suggesting a lack of a confirmed trend. The nearby resistance levels at 11.107 and 11.209 cap upside in the short term. Overall, the chart is range-bound to mildly bearish right now.

Positive Catalysts

  • No news in the past week, but the stock trend model suggests a favorable short-term statistical setup with a 90% chance of 1.3% next day upside, 5.4% next week upside, and 8.95% next month upside. Pre-market positioning near support also offers a modest tactical upside if the stock holds above 10.779.

Neutral/Negative Catalysts

  • No recent news, no significant hedge fund activity, no notable insider buying or selling, and no recent congress trading data. The MACD is negative and worsening, and there is no AI Stock Pick or SwingMax signal today, which removes a major bullish catalyst. Financial snapshot data is unavailable, so there is no recent quarter growth confirmation.

Financial Performance

Financial data is not available due to an error in the latest snapshot, so recent quarter revenue, earnings, and growth trends cannot be assessed. The latest quarter season could not be identified from the provided data.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no visible trend in Wall Street estimates. Based on the available information, analyst sentiment cannot be confirmed as bullish or supportive.

Wall Street analysts forecast GPAT stock price to rise
Analyst Rating
0
Wall Street analysts forecast GPAT stock price to rise
Buy
Hold
Sell
0
Current: 10.800
sliders
Low
0
Averages
0
High
0
0
Current: 10.800
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch